Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...

Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets.

Brands announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with ...

This was the stock's second consecutive day of losses.

Tilray Medical, a division of Tilray Brands, is adding new cannabis extract products to its German medical portfolio. A ...

Tilray Brands announces completion of Phase I of its cannabis supply chain growth plan, increasing production capacity and meeting global demand. Tilray Brands, Inc., a global leader in the ...

Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International ...

Tilray's primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets.